Dumont & Blake Investment Advisors’s GSK GSK Stock Holding History

Dumont & Blake Investment Advisors’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-12,422	Closed	-$609K	–	210
2025 Q4	$609K	Sell	12,422 -75	-0.6%	-$3.5K	0.15%	133
2025 Q3	$539K	Sell	12,497 -90	-0.7%	-$3.52K	0.13%	138
2025 Q2	$483K	Buy	12,587 +446	+4%	+$17K	0.13%	139
2025 Q1	$470K	Buy	12,141 +30	+0.2%	+$1.1K	0.13%	140
2024 Q4	$410K	Sell	12,111 -1,507	-11%	-$54.3K	0.11%	147
2024 Q3	$557K	Sell	13,618 -13,614	-50%	-$557K	0.15%	134
2024 Q2	$1.05M	Buy	+27,232	New	+$1.15M	0.15%	134

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Dumont & Blake Investment Advisors's GSK Position: Q1 2026 in Review

Dumont & Blake Investment Advisors sold out of GSK (GSK) in Q1 2026, closing a stake of 12,422 shares — an estimated $609K sold.

Dumont & Blake Investment Advisors first reported a position in GSK in Q2 2024 and held it in 7 quarters. The position peaked at $1.05M in Q2 2024. 1,035 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

Dumont & Blake Investment Advisors reported no remaining GSK position as of Q1 2026 after selling out during the quarter.
Dumont & Blake Investment Advisors sold 12,422 GSK shares in Q1 2026, an estimated $609K.
Dumont & Blake Investment Advisors first reported a position in GSK in Q2 2024 and held it in 7 quarters.
Dumont & Blake Investment Advisors's GSK position peaked at $1.05M in Q2 2024.
1,035 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Dumont & Blake Investment Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.